{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:11:12Z","timestamp":1794935472126,"version":"4.9.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD102909"],"award-info":[{"award-number":["R01HD102909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS094535"],"award-info":[{"award-number":["R01NS094535"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science Foundation","award":["IO2012106"],"award-info":[{"award-number":["IO2012106"]}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["BE-0048"],"award-info":[{"award-number":["BE-0048"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45627-6","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T05:22:41Z","timestamp":1778995361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transcriptomic and proteomic evidence for noncanonical hydrogen sulfide metabolism and immune dysregulation in Down Syndrome"],"prefix":"10.1038","volume":"16","author":[{"given":"Karthik","family":"Mouli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton V.","family":"Liopo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Suva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Derry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,17]]},"reference":[{"key":"45627_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis, S. E. et al. Down Syndrome. Nat. Rev. Dis. Primers. 6, 9. https:\/\/doi.org\/10.1038\/s41572-019-0143-7 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"45627_CR2","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1038\/s41467-024-49781-1","volume":"15","author":"MG Donovan","year":"2024","unstructured":"Donovan, M. G. et al. Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down Syndrome. Nat. Commun. 15, 5473. https:\/\/doi.org\/10.1038\/s41467-024-49781-1 (2024).","journal-title":"Nat. Commun."},{"key":"45627_CR3","doi-asserted-by":"publisher","unstructured":"Galbraith, M. D. et al. Multidimensional definition of the interferonopathy of Down Syndrome and its response to JAK inhibition. Science Advances 9, eadg6218, https:\/\/doi.org\/10.1126\/sciadv.adg6218","DOI":"10.1126\/sciadv.adg6218"},{"key":"45627_CR4","doi-asserted-by":"publisher","unstructured":"Ghezzi, M. et al. Recurrent respiratory infections in children with Down Syndrome: A review. Child. (Basel). 11 https:\/\/doi.org\/10.3390\/children11020246 (2024).","DOI":"10.3390\/children11020246"},{"key":"45627_CR5","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/erm.2021.6","volume":"23","author":"KAL Hasaart","year":"2021","unstructured":"Hasaart, K. A. L., Bertrums, E. J. M., Manders, F., Goemans, B. F. & van Boxtel, R. Increased risk of leukaemia in children with Down Syndrome: a somatic evolutionary view. Expert Rev. Mol. Med. 23, e5. https:\/\/doi.org\/10.1017\/erm.2021.6 (2021).","journal-title":"Expert Rev. Mol. Med."},{"key":"45627_CR6","doi-asserted-by":"publisher","first-page":"669893","DOI":"10.3389\/fimmu.2021.669893","volume":"12","author":"GE Marcovecchio","year":"2021","unstructured":"Marcovecchio, G. E. et al. Premature senescence and increased oxidative stress in the thymus of Down Syndrome patients. Front. Immunol. 12, 669893. https:\/\/doi.org\/10.3389\/fimmu.2021.669893 (2021).","journal-title":"Front. Immunol."},{"key":"45627_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","volume":"164","author":"G Ram","year":"2011","unstructured":"Ram, G. & Chinen, J. Infections and immunodeficiency in Down Syndrome. Clin. Exp. Immunol. 164, 9\u201316. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04335.x (2011).","journal-title":"Clin. Exp. Immunol."},{"key":"45627_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41586-024-07946-4","volume":"634","author":"AR Marderstein","year":"2024","unstructured":"Marderstein, A. R. et al. Single-cell multi-omics map of human fetal blood in Down Syndrome. Nature 634, 104\u2013112. https:\/\/doi.org\/10.1038\/s41586-024-07946-4 (2024).","journal-title":"Nature"},{"key":"45627_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fnins.2020.00670","volume":"14","author":"M Dierssen","year":"2020","unstructured":"Dierssen, M., Fructuoso, M., Mart\u00ednez de Lagr\u00e1n, M., Perluigi, M. & Barone, E. Down Syndrome is a metabolic disease: Altered insulin signaling mediates peripheral and brain dysfunctions. Front. Neurosci. 14, 670. https:\/\/doi.org\/10.3389\/fnins.2020.00670 (2020).","journal-title":"Front. Neurosci."},{"key":"45627_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/s0140-6736(03)12987-x","volume":"361","author":"NJ Roizen","year":"2003","unstructured":"Roizen, N. J. & Patterson, D. Down\u2019s syndrome. Lancet 361, 1281\u20131289. https:\/\/doi.org\/10.1016\/s0140-6736(03)12987-x (2003).","journal-title":"Lancet"},{"key":"45627_CR11","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1073\/pnas.0709451105","volume":"105","author":"JC Juarez","year":"2008","unstructured":"Juarez, J. C. et al. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. U S A. 105, 7147\u20137152. https:\/\/doi.org\/10.1073\/pnas.0709451105 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"45627_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2310\/6650.2001.34089","volume":"49","author":"T Gulesserian","year":"2001","unstructured":"Gulesserian, T., Seidl, R., Hardmeier, R., Cairns, N. & Lubec, G. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down Syndrome. J. Investig Med. 49, 41\u201346. https:\/\/doi.org\/10.2310\/6650.2001.34089 (2001).","journal-title":"J. Investig Med."},{"key":"45627_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s0891-5849(01)00609-8","volume":"31","author":"J Muchov\u00e1","year":"2001","unstructured":"Muchov\u00e1, J. et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down Syndrome patients. Free Radic Biol. Med. 31, 499\u2013508. https:\/\/doi.org\/10.1016\/s0891-5849(01)00609-8 (2001).","journal-title":"Free Radic Biol. Med."},{"key":"45627_CR14","doi-asserted-by":"publisher","unstructured":"Perluigi, M. & Butterfield, D. A. Oxidative stress and Down Syndrome: A route toward Alzheimer-like dementia. Curr. Gerontol. Geriatr. Res. 2012 (724904). https:\/\/doi.org\/10.1155\/2012\/724904 (2012).","DOI":"10.1155\/2012\/724904"},{"key":"45627_CR15","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/j.1471-4159.2009.06294.x","volume":"110","author":"K Ishihara","year":"2009","unstructured":"Ishihara, K. et al. Increased lipid peroxidation in Down\u2019s syndrome mouse models. J. Neurochem. 110, 1965\u20131976. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06294.x (2009).","journal-title":"J. Neurochem"},{"key":"45627_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tibs.2015.05.001","volume":"40","author":"A Perkins","year":"2015","unstructured":"Perkins, A., Nelson, K. J., Parsonage, D., Poole, L. B. & Karplus, P. A. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem. Sci. 40, 435\u2013445. https:\/\/doi.org\/10.1016\/j.tibs.2015.05.001 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"45627_CR17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1083\/jcb.134.4.849","volume":"134","author":"PE Purdue","year":"1996","unstructured":"Purdue, P. E. & Lazarow, P. B. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J. Cell. Biol. 134, 849\u2013862. https:\/\/doi.org\/10.1083\/jcb.134.4.849 (1996).","journal-title":"J. Cell. Biol."},{"key":"45627_CR18","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3390\/antiox13111361","volume":"13","author":"K Mouli","year":"2024","unstructured":"Mouli, K. et al. SOD1 is an integral yet insufficient oxidizer of hydrogen sulfide in Trisomy 21 B lymphocytes and can be augmented by a pleiotropic carbon nanozyme. Antioxidants 13, 1361 (2024).","journal-title":"Antioxidants"},{"key":"45627_CR19","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1111\/febs.15214","volume":"287","author":"C Szabo","year":"2020","unstructured":"Szabo, C. The re-emerging pathophysiological role of the cystathionine-\u03b2-synthase - hydrogen sulfide system in Down Syndrome. Febs j. 287, 3150\u20133160. https:\/\/doi.org\/10.1111\/febs.15214 (2020).","journal-title":"Febs j."},{"key":"45627_CR20","doi-asserted-by":"publisher","unstructured":"Szabo, C. Role of cystathionine-\u03b2-synthase and hydrogen sulfide in Down Syndrome. Neurotherapeutics e00584. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00584 (2025).","DOI":"10.1016\/j.neurot.2025.e00584"},{"key":"45627_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajmg.a.10847","volume":"116a","author":"P Kamoun","year":"2003","unstructured":"Kamoun, P., Belardinelli, M. C., Chabli, A. & Lallouchi, K. Chadefaux-Vekemans, B. Endogenous hydrogen sulfide overproduction in Down Syndrome. Am. J. Med. Genet. A. 116a, 310\u2013311. https:\/\/doi.org\/10.1002\/ajmg.a.10847 (2003).","journal-title":"Am. J. Med. Genet. A"},{"key":"45627_CR22","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1007\/s11357-024-01146-8","volume":"46","author":"T Panagaki","year":"2024","unstructured":"Panagaki, T. et al. Neurobehavioral dysfunction in a mouse model of Down Syndrome: upregulation of cystathionine \u03b2-synthase, H(2)S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy. Geroscience 46, 4275\u20134314. https:\/\/doi.org\/10.1007\/s11357-024-01146-8 (2024).","journal-title":"Geroscience"},{"key":"45627_CR23","doi-asserted-by":"publisher","unstructured":"Panagaki, T., Randi, E. B., Augsburger, F. & Szabo, C. Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down Syndrome. Proc. Natl. Acad. Sci. 116, 18769\u201318771 https:\/\/doi.org\/10.1073\/pnas.1911895116 (2019).","DOI":"10.1073\/pnas.1911895116"},{"key":"45627_CR24","doi-asserted-by":"publisher","unstructured":"Panagaki, T., Randi, E. B. & Szabo, C. Role of 3-mercaptopyruvate sulfurtransferase in the regulation of proliferation and cellular bioenergetics in human Down Syndrome fibroblasts. Biomolecules 10 https:\/\/doi.org\/10.3390\/biom10040653 (2020).","DOI":"10.3390\/biom10040653"},{"key":"45627_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.freeradbiomed.2016.02.028","volume":"95","author":"N Couto","year":"2016","unstructured":"Couto, N., Wood, J. & Barber, J. The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Radic Biol. Med. 95, 27\u201342. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.02.028 (2016).","journal-title":"Free Radic Biol. Med."},{"key":"45627_CR26","doi-asserted-by":"publisher","unstructured":"Pedre, B. & Dick, T. P. 3-Mercaptopyruvate sulfurtransferase: an enzyme at the crossroads of sulfane sulfur trafficking. 402, 223\u2013237 https:\/\/doi.org\/10.1515\/hsz-2020-0249 (2021).","DOI":"10.1515\/hsz-2020-0249"},{"key":"45627_CR27","doi-asserted-by":"publisher","first-page":"e2205044120","DOI":"10.1073\/pnas.2205044120","volume":"120","author":"CH Switzer","year":"2023","unstructured":"Switzer, C. H., Kasamatsu, S., Ihara, H. & Eaton, P. SOD1 is an essential H(2)S detoxifying enzyme. Proc. Natl. Acad. Sci. USA. 120, e2205044120. https:\/\/doi.org\/10.1073\/pnas.2205044120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"45627_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323. https:\/\/doi.org\/10.1186\/1471-2105-12-323 (2011).","journal-title":"BMC Bioinform."},{"key":"45627_CR29","doi-asserted-by":"publisher","unstructured":"Espinosa, J. The Human Trisome Project. https:\/\/doi.org\/10.71738\/P0A9-2V09 (2022).","DOI":"10.71738\/P0A9-2V09"},{"key":"45627_CR30","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the Tidyverse. J. Open. Source Softw. 4, 1686. https:\/\/doi.org\/10.21105\/joss.01686 (2019).","journal-title":"J. Open. Source Softw."},{"key":"45627_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"45627_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S L\u00ea","year":"2008","unstructured":"L\u00ea, S., Josse, J., Husson, F. & FactoMineR an R package for multivariate analysis. J. Stat. Softw. 25, 1\u201318. https:\/\/doi.org\/10.18637\/jss.v025.i01 (2008).","journal-title":"J. Stat. Softw."},{"key":"45627_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0166-4328(01)00297-2","volume":"125","author":"Y Benjamini","year":"2001","unstructured":"Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279\u2013284. https:\/\/doi.org\/10.1016\/s0166-4328(01)00297-2 (2001).","journal-title":"Behav. Brain Res."},{"key":"45627_CR34","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fgene.2019.00858","volume":"10","author":"E Ulgen","year":"2019","unstructured":"Ulgen, E., Ozisik, O., Sezerman, O. U. & pathfindR an R package for comprehensive identification of enriched pathways in omics data through active subnetworks. Front. Genet. 10, 858. https:\/\/doi.org\/10.3389\/fgene.2019.00858 (2019).","journal-title":"Front. Genet."},{"key":"45627_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","volume":"18","author":"A Fabregat","year":"2017","unstructured":"Fabregat, A. et al. Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinform. 18, 142. https:\/\/doi.org\/10.1186\/s12859-017-1559-2 (2017).","journal-title":"BMC Bioinform."},{"key":"45627_CR36","doi-asserted-by":"publisher","unstructured":"Vasilevsky, N. A. et al. Mondo: integrating disease terminology across communities. Genetics, iyaf215 https:\/\/doi.org\/10.1093\/genetics\/iyaf215 (2025).","DOI":"10.1093\/genetics\/iyaf215"},{"key":"45627_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782. https:\/\/doi.org\/10.1038\/s41587-019-0114-2 (2019).","journal-title":"Nat. Biotechnol."},{"key":"45627_CR38","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849. https:\/\/doi.org\/10.1093\/bioinformatics\/btw313 (2016).","journal-title":"Bioinformatics"},{"key":"45627_CR39","unstructured":"Pedersen, T. L. ggforce: Accelerating \u2018ggplot2\u2019. (2025)."},{"key":"45627_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","volume":"24","author":"A Izzo","year":"2018","unstructured":"Izzo, A. et al. Mitochondrial dysfunction in Down Syndrome: molecular mechanisms and therapeutic targets. Mol. Med. 24, 2. https:\/\/doi.org\/10.1186\/s10020-018-0004-y (2018).","journal-title":"Mol. Med."},{"key":"45627_CR41","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2164-12-229","volume":"12","author":"M Vilardell","year":"2011","unstructured":"Vilardell, M. et al. Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genom. 12, 229. https:\/\/doi.org\/10.1186\/1471-2164-12-229 (2011).","journal-title":"BMC Genom."},{"key":"45627_CR42","unstructured":"Kepler Mapper. A flexible Python implementation of the Mapper algorithm v. v2.0.1 (Zenodo, 2021)."},{"key":"45627_CR43","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.21105\/joss.01315","volume":"4","author":"HJ van Veen","year":"2019","unstructured":"van Veen, H. J., Saul, N., Eargle, D. & Mangham, S. W. Kepler Mapper: A flexible Python implementation of the Mapper algorithm. J. Open. Source Softw. 4, 1315. https:\/\/doi.org\/10.21105\/joss.01315 (2019).","journal-title":"J. Open. Source Softw."},{"key":"45627_CR44","doi-asserted-by":"publisher","unstructured":"Liu, F. T., Ting, K. M. & Zhou, Z. H. Isolation-based anomaly detection. ACM Trans. Knowl. Discov Data. 6, Article 3, https:\/\/doi.org\/10.1145\/2133360.2133363 (2012).","DOI":"10.1145\/2133360.2133363"},{"key":"45627_CR45","unstructured":"Singh, G., Memoli, F. & Carlsson, G. Eurographics Symposium on Point-Based Graphics (eds M. Botsch, R. Pajarola, B. Chen, & M. Zwicker) (The Eurographics Association, 2007)."},{"key":"45627_CR46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","volume":"31","author":"F Murtagh","year":"2014","unstructured":"Murtagh, F. & Legendre, P. Ward\u2019s hierarchical agglomerative clustering method: Which algorithms implement ward\u2019s criterion? J. Classif. 31, 274\u2013295. https:\/\/doi.org\/10.1007\/s00357-014-9161-z (2014).","journal-title":"J. Classif."},{"key":"45627_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.13253","volume":"162","author":"F Sun","year":"2021","unstructured":"Sun, F. et al. The role of hydrogen sulphide signalling in macrophage activation. Immunology 162, 3\u201310. https:\/\/doi.org\/10.1111\/imm.13253 (2021).","journal-title":"Immunology"},{"key":"45627_CR48","doi-asserted-by":"publisher","first-page":"e2202380","DOI":"10.1002\/adhm.202202380","volume":"12","author":"W Geng","year":"2023","unstructured":"Geng, W. et al. Nitric oxide scavenging and hydrogen sulfide production synergistically treat rheumatoid arthritis. Adv. Healthc. Mater. 12, e2202380. https:\/\/doi.org\/10.1002\/adhm.202202380 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"45627_CR49","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1089\/ars.2012.5041","volume":"19","author":"R Greiner","year":"2013","unstructured":"Greiner, R. et al. Polysulfides link H2S to protein thiol oxidation. Antioxid. Redox Signal. 19, 1749\u20131765. https:\/\/doi.org\/10.1089\/ars.2012.5041 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"45627_CR50","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/cbic.202000661","volume":"22","author":"AP Landry","year":"2021","unstructured":"Landry, A. P., Ballou, D. P. & Banerjee, R. Hydrogen sulfide oxidation by sulfide quinone oxidoreductase. Chembiochem 22, 949\u2013960. https:\/\/doi.org\/10.1002\/cbic.202000661 (2021).","journal-title":"Chembiochem"},{"key":"45627_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.smim.2009.02.006","volume":"21","author":"MK MacLeod","year":"2009","unstructured":"MacLeod, M. K., Clambey, E. T., Kappler, J. W. & Marrack, P. CD4 memory T cells: what are they and what can they do? Semin Immunol. 21, 53\u201361. https:\/\/doi.org\/10.1016\/j.smim.2009.02.006 (2009).","journal-title":"Semin Immunol."},{"key":"45627_CR52","doi-asserted-by":"publisher","unstructured":"Raphael, I., Joern, R. R. & Forsthuber, T. G. Memory CD4(+) T cells in immunity and autoimmune diseases. Cells 9 https:\/\/doi.org\/10.3390\/cells9030531 (2020).","DOI":"10.3390\/cells9030531"},{"key":"45627_CR53","doi-asserted-by":"publisher","unstructured":"Niewold, T. B., Lehman, J. S., Gunnarsson, I., Meves, A. & Oke, V. Role of interleukin-16 in human diseases: a novel potential therapeutic target. Front. Immunol. 16\u20132025. https:\/\/doi.org\/10.3389\/fimmu.2025.1524026 (2025).","DOI":"10.3389\/fimmu.2025.1524026"},{"key":"45627_CR54","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv, L. B. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545\u2013558. https:\/\/doi.org\/10.1038\/s41577-018-0029-z (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"45627_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","volume":"615","author":"L Malle","year":"2023","unstructured":"Malle, L. et al. Autoimmunity in Down\u2019s syndrome via cytokines, CD4 T cells and CD11c(+) B cells. Nature 615, 305\u2013314. https:\/\/doi.org\/10.1038\/s41586-023-05736-y (2023).","journal-title":"Nature"},{"key":"45627_CR56","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013d646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"key":"45627_CR57","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","volume":"52","author":"M Milacic","year":"2024","unstructured":"Milacic, M. et al. The reactome pathway knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013d678. https:\/\/doi.org\/10.1093\/nar\/gkad1025 (2024).","journal-title":"Nucleic Acids Res."},{"key":"45627_CR58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0304-3940(97)00748-9","volume":"235","author":"R Seidl","year":"1997","unstructured":"Seidl, R. et al. Evidence against increased oxidative DNA-damage in Down Syndrome. Neurosci. Lett. 235, 137\u2013140. https:\/\/doi.org\/10.1016\/s0304-3940(97)00748-9 (1997).","journal-title":"Neurosci. Lett."},{"key":"45627_CR59","doi-asserted-by":"publisher","unstructured":"Sadowska-Bartosz, I. & Bartosz, G. Peroxiredoxin 2: An important element of the antioxidant defense of the erythrocyte. Antioxid. (Basel). 12 https:\/\/doi.org\/10.3390\/antiox12051012 (2023).","DOI":"10.3390\/antiox12051012"},{"key":"45627_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2022.04.015","volume":"186","author":"KM Prutton","year":"2022","unstructured":"Prutton, K. M. et al. Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21. Free Radic. Biol. Med. 186, 32\u201342. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.04.015 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"45627_CR61","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.mbplus.2021.100057","volume":"10","author":"P Hiebert","year":"2021","unstructured":"Hiebert, P. The Nrf2 transcription factor: A multifaceted regulator of the extracellular matrix. Matrix Biol. Plus. 10, 100057. https:\/\/doi.org\/10.1016\/j.mbplus.2021.100057 (2021).","journal-title":"Matrix Biology Plus"},{"key":"45627_CR62","doi-asserted-by":"publisher","first-page":"114365","DOI":"10.1016\/j.bcp.2020.114365","volume":"184","author":"S Nirgude","year":"2021","unstructured":"Nirgude, S. & Choudhary, B. Insights into the role of GPX3, a highly efficient plasma antioxidant, in cancer. Biochem. Pharmacol. 184, 114365. https:\/\/doi.org\/10.1016\/j.bcp.2020.114365 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"45627_CR63","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-019-1752-5","volume":"10","author":"M Bordi","year":"2019","unstructured":"Bordi, M. et al. mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy. Cell. Death Dis. 10, 563. https:\/\/doi.org\/10.1038\/s41419-019-1752-5 (2019).","journal-title":"Cell. Death Dis."},{"key":"45627_CR64","doi-asserted-by":"publisher","first-page":"2211241","DOI":"10.1002\/adma.202211241","volume":"36","author":"PJ Derry","year":"2024","unstructured":"Derry, P. J. et al. Oxidation of hydrogen sulfide to polysulfide and thiosulfate by a carbon nanozyme: Therapeutic implications with an emphasis on Down Syndrome. Adv. Mater. 36, 2211241. https:\/\/doi.org\/10.1002\/adma.202211241 (2024).","journal-title":"Adv. Mater."},{"key":"45627_CR65","doi-asserted-by":"publisher","first-page":"40227","DOI":"10.1038\/srep40227","volume":"7","author":"K Hanaoka","year":"2017","unstructured":"Hanaoka, K. et al. Discovery and mechanistic characterization of selective inhibitors of H(2)S-producing enzyme: 3-mercaptopyruvate sulfurtransferase (3MST) targeting active-site cysteine persulfide. Sci. Rep. 7, 40227. https:\/\/doi.org\/10.1038\/srep40227 (2017).","journal-title":"Sci. Rep."},{"key":"45627_CR66","doi-asserted-by":"publisher","unstructured":"Hip\u00f3lito, A., Nunes, S. C., Vicente, J. B. & Serpa, J. Cysteine aminotransferase (CAT): A pivotal sponsor in metabolic remodeling and an ally of 3-mercaptopyruvate sulfurtransferase (MST) in cancer. Molecules 25 https:\/\/doi.org\/10.3390\/molecules25173984 (2020).","DOI":"10.3390\/molecules25173984"},{"key":"45627_CR67","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.lfs.2013.08.017","volume":"93","author":"TR Garlet","year":"2013","unstructured":"Garlet, T. R. et al. Systemic oxidative stress in children and teenagers with Down Syndrome. Life Sci. 93, 558\u2013563. https:\/\/doi.org\/10.1016\/j.lfs.2013.08.017 (2013).","journal-title":"Life Sci."},{"key":"45627_CR68","doi-asserted-by":"publisher","first-page":"e0176307","DOI":"10.1371\/journal.pone.0176307","volume":"12","author":"S Aivazidis","year":"2017","unstructured":"Aivazidis, S. et al. The burden of trisomy 21 disrupts the proteostasis network in Down Syndrome. PLoS One. 12, e0176307. https:\/\/doi.org\/10.1371\/journal.pone.0176307 (2017).","journal-title":"PLoS One"},{"key":"45627_CR69","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1515\/cclm.1988.26.5.255","volume":"26","author":"J Gromadzi\u0144ska","year":"1988","unstructured":"Gromadzi\u0144ska, J., Wasowicz, W., Sktodowska, M. & Str\u00f3\u017cy\u0144ski, H. Glutathione peroxidase activity, lipid peroxides and selenium status in blood in patients with Down\u2019s syndrome. Clin. Chem. Lab. Med. (CCLM). 26, 255\u2013258. https:\/\/doi.org\/10.1515\/cclm.1988.26.5.255 (1988).","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"45627_CR70","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00042752-200607000-00013","volume":"16","author":"O Francisco Javier","year":"2006","unstructured":"Francisco Javier, O., Manuel, R. & Manuel, R. R. Regular physical activity increases glutathione peroxidase activity in adolescents with Down Syndrome. Clin. J. Sport Med. 16, 355\u2013356. https:\/\/doi.org\/10.1097\/00042752-200607000-00013 (2006).","journal-title":"Clin. J. Sport Med."},{"key":"45627_CR71","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00018-003-3048-1","volume":"60","author":"MF S\u00e1nchez-Font","year":"2003","unstructured":"S\u00e1nchez-Font, M. F. et al. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down Syndrome fetal brains. Cell. Mol. Life Sci. 60, 1513\u20131523. https:\/\/doi.org\/10.1007\/s00018-003-3048-1 (2003).","journal-title":"Cell. Mol. Life Sci."},{"key":"45627_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","volume":"66","author":"J Lu","year":"2014","unstructured":"Lu, J. & Holmgren, A. The thioredoxin antioxidant system. Free Radic. Biol. Med. 66, 75\u201387. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.07.036 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"45627_CR73","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1016\/j.freeradbiomed.2018.10.354","volume":"128","author":"J Roede","year":"2018","unstructured":"Roede, J. 324 - Investigation of cytoplasmic and mitochondrial redox status in Down Syndrome: impact of the thioredoxin and glutathione systems. Free Radic. Biol. Med. 128, S134. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.354 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"45627_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","volume":"30","author":"HJ Forman","year":"2009","unstructured":"Forman, H. J., Zhang, H. & Rinna, A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol. Aspects Med. 30, 1\u201312. https:\/\/doi.org\/10.1016\/j.mam.2008.08.006 (2009).","journal-title":"Mol. Aspects Med."},{"key":"45627_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mam.2008.08.009","volume":"30","author":"CC Franklin","year":"2009","unstructured":"Franklin, C. C. et al. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol. Aspects Med. 30, 86\u201398. https:\/\/doi.org\/10.1016\/j.mam.2008.08.009 (2009).","journal-title":"Mol. Aspects Med."},{"key":"45627_CR76","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1086\/321262","volume":"69","author":"M Pogribna","year":"2001","unstructured":"Pogribna, M. et al. Homocysteine metabolism in children with Down Syndrome: in vitro modulation. Am. J. Hum. Genet. 69, 88\u201395. https:\/\/doi.org\/10.1086\/321262 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"45627_CR77","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2174\/092986706776360914","volume":"13","author":"N Nagahara","year":"2006","unstructured":"Nagahara, N. & Sawada, N. The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase. Curr. Med. Chem. 13, 1219\u20131230. https:\/\/doi.org\/10.2174\/092986706776360914 (2006).","journal-title":"Curr. Med. Chem."},{"key":"45627_CR78","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1089\/ars.2020.8132","volume":"33","author":"KR Olson","year":"2020","unstructured":"Olson, K. R. Are reactive sulfur species the new reactive oxygen species? Antioxid. Redox. Signal. 33, 1125\u20131142. https:\/\/doi.org\/10.1089\/ars.2020.8132 (2020).","journal-title":"Antioxid. Redox. Signal."},{"key":"45627_CR79","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s40200-022-01087-z","volume":"21","author":"NA Meguid","year":"2022","unstructured":"Meguid, N. A. et al. Differential expression of cystathionine beta synthase in adolescents with Down Syndrome: impact on adiposity. J. Diabetes Metab. Disord. 21, 1491\u20131497. https:\/\/doi.org\/10.1007\/s40200-022-01087-z (2022).","journal-title":"J. Diabetes Metab. Disord"},{"key":"45627_CR80","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1042\/bj20110841","volume":"439","author":"Y Mikami","year":"2011","unstructured":"Mikami, Y. et al. Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem. J. 439, 479\u2013485. https:\/\/doi.org\/10.1042\/bj20110841 (2011).","journal-title":"Biochem. J."},{"key":"45627_CR81","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","volume":"17","author":"P Helguera","year":"2013","unstructured":"Helguera, P. et al. Adaptive downregulation of mitochondrial function in Down Syndrome. Cell. Metab. 17, 132\u2013140. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.005 (2013).","journal-title":"Cell. Metab."},{"key":"45627_CR82","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/antiox12020344","volume":"12","author":"E Marini","year":"2023","unstructured":"Marini, E. et al. Comparative study of different H2S donors as vasodilators and attenuators of superoxide-induced endothelial damage. Antioxidants 12, 344 (2023).","journal-title":"Antioxidants"},{"key":"45627_CR83","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2017.12.010","volume":"149","author":"KR Olson","year":"2018","unstructured":"Olson, K. R. H2S and polysulfide metabolism: Conventional and unconventional pathways. Biochem. Pharmacol. 149, 77\u201390. https:\/\/doi.org\/10.1016\/j.bcp.2017.12.010 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"45627_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/ars.2023.0352","volume":"39","author":"T Vignane","year":"2023","unstructured":"Vignane, T. & Filipovic, M. R. Emerging chemical biology of protein persulfidation. Antioxid. Redox Signal. 39, 19\u201339. https:\/\/doi.org\/10.1089\/ars.2023.0352 (2023).","journal-title":"Antioxid. Redox Signal."},{"key":"45627_CR85","doi-asserted-by":"publisher","first-page":"eaax8358","DOI":"10.1126\/sciadv.aax8358","volume":"6","author":"\u00c9 D\u00f3ka","year":"2020","unstructured":"D\u00f3ka, \u00c9. et al. Control of protein function through oxidation and reduction of persulfidated states. Sci. Adv. 6, eaax8358. https:\/\/doi.org\/10.1126\/sciadv.aax8358 (2020).","journal-title":"Sci. Adv."},{"key":"45627_CR86","doi-asserted-by":"publisher","unstructured":"Cunha-Oliveira, T. et al. Oxidative stress in amyotrophic lateral sclerosis: Pathophysiology and opportunities for pharmacological intervention. Oxid. Med. Cell. Longev. 2020 (5021694). https:\/\/doi.org\/10.1155\/2020\/5021694 (2020).","DOI":"10.1155\/2020\/5021694"},{"key":"45627_CR87","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.24372","volume":"77","author":"A Davoli","year":"2015","unstructured":"Davoli, A. et al. Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis. Ann. Neurol. 77, 697\u2013709. https:\/\/doi.org\/10.1002\/ana.24372 (2015).","journal-title":"Ann. Neurol."},{"key":"45627_CR88","doi-asserted-by":"publisher","unstructured":"Spalloni, A. et al. Impact of pharmacological inhibition of hydrogen sulphide production in the SOD1G93A-ALS mouse model. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20102550 (2019).","DOI":"10.3390\/ijms20102550"},{"key":"45627_CR89","doi-asserted-by":"publisher","unstructured":"Guareschi, S. et al. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. 109, 5074\u20135079 https:\/\/doi.org\/10.1073\/pnas.1115402109 (2012).","DOI":"10.1073\/pnas.1115402109"},{"key":"45627_CR90","doi-asserted-by":"publisher","first-page":"12571","DOI":"10.1073\/pnas.220417997","volume":"97","author":"JA Johnston","year":"2000","unstructured":"Johnston, J. A., Dalton, M. J., Gurney, M. E. & Kopito, R. R. Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. 97, 12571\u201312576. https:\/\/doi.org\/10.1073\/pnas.220417997 (2000).","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45627-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45627-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:32:00Z","timestamp":1784183520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45627-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,17]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45627"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45627-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8535243\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,17]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The universities own intellectual property on H\n                      2\n                      S oxidation with application to DS-related accelerated aging, for which PJD. and TAK. are inventors. Conflicts of interest for PJD. and TAK. are mitigated through regular disclosure to and compliance with the Texas A&M Office of Sponsored Programs.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22330"}}